(Q44778668)

6 December 2017

Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity (English)

1 reference

6 December 2017

1 reference

Mathus-Vliegen EM

1

1 reference

6 December 2017

Van Ierland-Van Leeuwen ML

series ordinal

2

1 reference

6 December 2017

Terpstra A

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Alimentary Pharmacology & Therapeutics

6 December 2017

1 reference

6 December 2017

19

1 reference

6 December 2017

5

1 reference

6 December 2017

601-611

1 reference

AGA technical review on obesity

6 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Gallstone formation during weight-reduction dieting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Contributions of obesity and weight loss to gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Pathogenesis and treatment of gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Long-term weight patterns and risk for cholecystectomy in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2004.01812.X

10.1046/J.1365-2036.2004.01812.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference